Melanoma (stage III or IV) - ipilimumab: addendum by Liverpool reviews and implementation group (LRiG)
Melanoma (stage III or IV) - ipilimumab: addendum by Liverpool reviews and implementation group (LRiG)
02 November 2012 (302 Kb 27 sec) |
This page was last updated: 31 October 2012